Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Bieniasz

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
AIDS Alert|February 28, 2002
HIV/Ebola comparison could spur new treatmentsPaul Bieniasz
Annual Review of Virology|July 27, 2018
Multiple, Switchable Protein:RNA Interactions Regulate Human Immunodeficiency Virus Type 1 AssemblyPaul Bieniasz, Alice Telesnitsky
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 22, 2009
Human immunodeficiency virus, restriction factors, and interferonStuart Neil, Paul Bieniasz
Retrovirology|August 29, 2021
Derivation and characterization of an HIV-1 mutant that rescues IP<sub>6</sub> binding deficiencyDaniel Poston, Trinity Zang, Paul Bieniasz
Medrxiv : the Preprint Server for Health Sciences|October 14, 2020
Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infectionDaniel Poston, Yiska Weisblum, Helen Wise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2020
Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus InfectionDaniel Poston, Yiska Weisblum, Helen Wise, et al.
AIDS Research and Human Retroviruses|January 12, 2019
Short Communication: Ultrasensitive Immunoassay for Assessing Residual Simian-Tropic HIV in Nonhuman Primate Models of AIDSAdrienne E Swanstrom, Alison Jacques, Gregory Q Del Prete, et al.
Nature|April 12, 2011
A diverse range of gene products are effectors of the type I interferon antiviral responseJohn W Schoggins, Sam J Wilson, Maryline Panis, et al.
Plos Pathogens|April 27, 2010
The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherinClaire Pardieu, Raphaël Vigan, Sam J Wilson, et al.
Research Square|December 16, 2024
Disruption of CPSF6 enhances cellular permissivity to HIV-1 infection through alternative polyadenylationJudd Hultquist, Daphne Cornish, Kathryn Jackson-Jones, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
AIDS Alert|February 28, 2002
HIV/Ebola comparison could spur new treatmentsPaul Bieniasz
Annual Review of Virology|July 27, 2018
Multiple, Switchable Protein:RNA Interactions Regulate Human Immunodeficiency Virus Type 1 AssemblyPaul Bieniasz, Alice Telesnitsky
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 22, 2009
Human immunodeficiency virus, restriction factors, and interferonStuart Neil, Paul Bieniasz
Retrovirology|August 29, 2021
Derivation and characterization of an HIV-1 mutant that rescues IP<sub>6</sub> binding deficiencyDaniel Poston, Trinity Zang, Paul Bieniasz
Medrxiv : the Preprint Server for Health Sciences|October 14, 2020
Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infectionDaniel Poston, Yiska Weisblum, Helen Wise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2020
Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus InfectionDaniel Poston, Yiska Weisblum, Helen Wise, et al.
AIDS Research and Human Retroviruses|January 12, 2019
Short Communication: Ultrasensitive Immunoassay for Assessing Residual Simian-Tropic HIV in Nonhuman Primate Models of AIDSAdrienne E Swanstrom, Alison Jacques, Gregory Q Del Prete, et al.
Nature|April 12, 2011
A diverse range of gene products are effectors of the type I interferon antiviral responseJohn W Schoggins, Sam J Wilson, Maryline Panis, et al.
Plos Pathogens|April 27, 2010
The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherinClaire Pardieu, Raphaël Vigan, Sam J Wilson, et al.
Research Square|December 16, 2024
Disruption of CPSF6 enhances cellular permissivity to HIV-1 infection through alternative polyadenylationJudd Hultquist, Daphne Cornish, Kathryn Jackson-Jones, et al.
Pageof 2